Abstract:Diagnostic approaches capable of ultrasensitive pathogen detection from low-volume clinical samples, running without any sophisticated instrument and laboratory setup, are easily field-deployable, inexpensive, and rapid, and are considered ideal for monitoring disease progression and surveillance. However, standard pathogen detection methods, including culture and microscopic observation, antibody-based serologic tests, and primarily polymerase chain reaction (PCR)-oriented nucleic acid screening techniques, have shortcomings that limit their widespread use in responding to outbreaks and regular diagnosis, especially in remote resource-limited settings (RLSs). Recently, clustered regularly interspaced short palindromic repeats (CRISPR)-based programmable technology has emerged to challenge the unmet criteria of conventional methods. It consists of CRISPR-associated proteins (Cas) capable of targeting virtually any specific RNA or DNA genome based on the guide RNA (gRNA) sequence. Furthermore, the discovery of programmable trans-cleavage Cas proteins like Cas12a and Cas13 that can collaterally damage reporter-containing single-stranded DNA or RNA upon formation of target Cas-gRNA complex has strengthened this technology with enhanced sensitivity. Current advances, including automated multiplexing, ultrasensitive single nucleotide polymorphism (SNP)-based screening, inexpensive paper-based lateral flow readouts, and ease of use in remote global settings, have attracted the scientific community to introduce this technology in nucleic-acid-based precise detection of bacterial and viral pathogens at the point of care (POC). This review highlights CRISPR-Cas-based molecular technologies in diagnosing several tropical diseases, namely malaria, zika, chikungunya, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV-AIDS), tuberculosis (TB), and rabies.

Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods

CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives

Pathogen Detection Strategy Based on CRISPR

Next-generation CRISPR-based Diagnostic Tools for Human Diseases

CRISPR-Cas- and Aptamer-based Systems for Diagnosing Pathogens: A Review

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

CRISPR: The Frontier Technology of Next-Generation RNA Detection

CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics

Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens

Application of the CRISPR/Cas System in Pathogen Detection: A Review

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

CRISPR Cas system: A strategic approach in detection of nucleic acids

Recent Improvements in CRISPR-Based Amplification-Free Pathogen Detection

CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms

CRISPR-based nucleic acid diagnostics for pathogens

Recent advances in the CRISPR/Cas system-based visual detection method

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-Based Programmable Nucleic Acid-Binding Protein Technology Can Specifically Detect Fatal Tropical Disease-Causing Pathogens